Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge.
Loftager
M K
MK
Department of Clinical Studies, Royal Veterinary and Agricultural University, Copenhagen, Denmark.
Eriksen
L
L
Nielsen
R
R
D000189:Actinobacillus Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D016977:Actinobacillus pleuropneumoniae / Q000145:classification / Q000276:immunology*; D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000336:Aerosols; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood; D000942:Antigens, Bacterial / Q000008:administration & dosage; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology; D018928:Immunity, Mucosal; D007070:Immunoglobulin A / Q000097:blood; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000097:blood; D009297:Nasal Mucosa / Q000276:immunology; D011001:Pleuropneumonia / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D062605:Quillaja Saponins; D012463:Saliva / Q000276:immunology; D012503:Saponins / Q000008:administration & dosage; D012703:Serotyping; D013552:Swine; D013553:Swine Diseases / Q000276:immunology / Q000517:prevention & control
D000276:Adjuvants, Immunologic; D000336:Aerosols; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D062605:Quillaja Saponins; D012503:Saponins; C046386:Quil A